期刊文献+

HPLC-MS/MS法测定人血浆中地佐辛的浓度及其应用 被引量:6

A Sensitive HPLC MS/MS Method for Determination of Dezocine in Human Plasma and Its Application
下载PDF
导出
摘要 目的:建立快速测定人血浆中地佐辛浓度的HPLC-MS/MS方法,用于地佐辛口服液的绝对生物利用度预实验研究。方法:以坦洛新为内标,血浆经乙腈沉淀后进行HPLC-MS/MS分析。色谱柱:Aglient SB-C18column(2.1 mm×50 mm,3.5μm),流动相为5 mmol·L-1醋酸铵(含0.1%甲酸)-乙腈(65∶35,v/v)。地佐辛和内标在多反应监测正离子模式下的离子对分别为m/z246.2→97.2和409.2→228.0。结果:地佐辛在0.100~50.0 ng·m L-1范围内线性关系良好,检测方法的批内和批间精密度和准确度符合中国药典附录的相关要求,方法被成功应用于地佐辛口服液的人体绝对生物利用度预实验研究。结论:建立的HPLC-MS/MS法可以快速测定血浆中地佐辛的浓度;预实验结果显示地佐辛口服液的人体绝对生物利用度为5.3%。 Objective: To study the absoulte bioavailability of dezocine oral liquid, a rapid HPLC-MS/ MS for the determination of dezoeine in human plasma wasdeveloped and applied. Methods: Sample preparation was performed through a simple protein precipitation by acetonitrile. The chromatographic separation was achieved on an Aglient SB-C188 column (2.1 mm×50mm, 3.5 μm) with the mobile phase of acetonitrile and 5 mmol-L-1 of ammonium acetate buffer solution containing 0.1% formic acid. Mass spectrometer was operated in multiple reaction monitoring mode with positive electrospray ionization at m/z 246.2→97.2 for dezocine and m/z 409.2→228.0 for tamsulosin, respectively. Results: The method showed good linearity within the concentration range of 0.100-50.0ng.mL-1 for dezoeine in plasma. The intra- and inter-batch precision of dezocine meet the criterias of Chinese Pharmacopoeia Appendix. The method was successfully applied to the pilot study of absoulte bioavailability of dezocine oral liquid. Conclusion: An accurate, simple and reliable HPLC-MS/MS method was developed. The pilot study result showed that the absolute bioavailability of dezoeine oral liquid was 5.3%.
出处 《药学与临床研究》 2018年第1期14-17,共4页 Pharmaceutical and Clinical Research
基金 国家自然科学基金面上项目(81673390) 江苏省基础研究计划(自然科学基金)项目(BK20151445) 药物质量与安全预警教育部重点实验室资助项目(DQCP2017MS01)
关键词 地佐辛 HPLC-MS/MS 绝对生物利用度 Dezocine HPLC-MS/MS Absolute bioavailability
  • 相关文献

参考文献2

二级参考文献23

  • 1徐国柱,蔡志基.镇痛药临床评价方法研究[J].中国新药杂志,1995,4(4):20-22. 被引量:256
  • 2O'Brien JJ,Benfield P.Dezocine.A preliminary review of its phar-macodynamic and pharmacokinetic properties,and therapeutic effi-cacy[J].Drugs,1989,38(2):226-248.
  • 3Locniskar A,Greenblatt DJ,Zinny MA.Pharmacokinetics of dezo-cine,a new analgesic:effect of dose and route of administration[J].Eur J Clin Pharmacol,1986,30(1):121-123.
  • 4Pandit UA,Kothary SP,Pandit SK.Intravenous dezocine for post-operative pain:a double-blind,placebo-controlled comparison withmorphine[J].J Clin Pharmacol,1986,26(4):275-280.
  • 5Cohen RI,Edwards WT,Kezer EA,et al.Serial intravenous dosesof dezocine,morphine,and nalbuphine in the management of post-operative pain for outpatients[J].Anesth Analg,1993,77(3):533-539.
  • 6Jasinski DR,Preston KL.Assessment of dezocine for morphme-hke-morphine-like subjective effects and miosis[J].Clin Pharmacol T-her,1985,38(5):544-548.
  • 7Moiniche S,Kehlet H,Dahl JB.A qualitative and quantitative sys-tematic review of preemptive analgesia for postoperative pain relief:the role of timing of analgesia[J].Anesthesiology,2002,96(3):725-741.
  • 8Dahl JB,Miniche S.Pre-emptive analgesia[J].Br Med Bull,2004,71:13-27.
  • 9冯洁,耿立成.氟比洛芬酯脂微球注射液临床应用新进展[J].医学综述,2009,15(17):2676-2678. 被引量:14
  • 10刘俊,徐越峰.地佐辛应用于瑞芬太尼静脉麻醉术后痛觉过敏观察[J].中国医疗前沿,2009,4(24):15-16. 被引量:153

共引文献130

同被引文献49

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部